Onychomycosis is a fungal infection of the nails, typically affecting the toenails more than the fingernails. Treatment for onychomycosis involves using antifungal medications, which can be topical (applied directly to the nail) or oral (taken by mouth). In more severe cases, the treatment may include laser therapy, debridement (removal of the infected part of the nail), or even surgical removal of the nail. The choice of treatment depends on the severity of the infection, the type of fungus, and the patient's overall health.
Onychomycosis Treatment Market Overview
Global Onychomycosis Treatment Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031
Onychomycosis is a fungal infection of the nails caused by various fungi, including dermatophytes, non-dermatophyte molds, and yeasts, primarily Candida species. Dermatophytes, particularly Trichophyton rubrum, are responsible for about 80% of toenail infections. Clinically, onychomycosis is categorized into several types: distal and lateral subungual onychomycosis (DLSO), superficial white onychomycosis (SWO), proximal subungual onychomycosis (PSO), candidal onychomycosis, and total dystrophic onychomycosis.
Request for free sample:https://www.datamintelligence.com/download-sample/onychomycosis-treatment-market
Onychomycosis Treatment Market Dynamics
Onychomycosis is a widespread fungal infection that affects a significant portion of the global population. With increased awareness and advancements in diagnostic methods, more cases are being identified, resulting in a growing demand for treatments.
Onychomycosis is particularly more prevalent among individuals with diabetes, who are also at a higher risk of severe complications from the infection. According to the International Diabetes Federation, in 2021, approximately 537 million adults aged 20-79 years were living with diabetes—about 1 in 10 people. This number is projected to increase to 643 million by 2030 and 783 million by 2045, which is expected to contribute to the expansion of the onychomycosis treatment market.
Get your customized report @https://www.datamintelligence.com/customize/onychomycosis-treatment-market
Onychomycosis Treatment Market is segmented
By Type: Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candida Onychomycosis, Total Dystrophic Onychomycosis
By Treatment Type: Oral therapy, Topical Therapy, Photodynamic Therapy, Ciclopirox Nail Lacquers, Others
By End User: Hospitals, Clinics, Others
By Region: North America, Europe, South America, Asia Pacific, Middle East, and Africa
Onychomycosis Treatment Market Competitive Landscape
- Bausch Health Companies Inc
- Novartis AG
- Pfizer, Inc
- Moberg Pharma AB
- Bayer AG
- Dr. Reddy’s Laboratories Ltd
- Gladerma
- Medimetriks Pharmaceuticals, Inc
- Kaken Pharmaceuticals
- Hahn Medical Systems
Related Reports
Polyarticular Juvenile Idiopathic Arthritis Drugs Market
Contact Us:
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Contact Person: Sai. K
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek